Profile
SONN VRTX ALNY REGN ARGX SGEN
Company Name Sonnet BioTherapeutics Holdings, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $50.74M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.01K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Raghu Rao Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
SONN VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
SONN VRTX ALNY REGN ARGX SGEN
Last Close $6.2 $383.12 $453.56 $591.99 $736.76 $228.74
High 52 $9.77 $516.74 $482.13 $1145.03 $768 $228.74
Low 52 $0.71 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -36.54 % -25.86 % -5.93 % -48.3 % -4.07 % 0 %
Price vs. 52 Week Low 773.24 % 4.52 % 101.96 % 22.59 % 41.75 % 0 %
Total Return
SONN VRTX ALNY REGN ARGX SGEN
1 Month Return 94.36 % -2.85 % -0.97 % 0.13 % 11.48 % 0 %
3 Month Return 421.01 % -13.1 % 46.45 % 16.14 % 35.9 % 0 %
6 Month Return 324.66 % -24.88 % 78.81 % -10.65 % 20.02 % 0 %
9 Month Return 297.44 % -3.56 % 84.79 % -15.65 % 18.1 % 0 %
YTD Return 324.66 % -4.86 % 92.75 % -16.89 % 19.8 % 0 %
1 Year Return 520 % -17.59 % 65.61 % -48.3 % 38.23 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SONN VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
SONN VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -95.19 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -659.56 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -4648.06 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM 461.47 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 101.18 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 95.3 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -1405.87 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -14978.45 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 1.67 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.02 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 1290.42 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 48.65 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.6 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -2.6 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 8.1 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -1031.07 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -14978.45 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -4.92 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -2.92 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -2.92 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
SONN VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -11.35 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
SONN VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $-0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
SONN VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.85
AARD Aardvark Therapeutics, Inc. Common Stock 10.89
ABCL AbCellera Biologics Inc. 4.51
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.38
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.26
ABPWW 0.041
ABSI Absci Corporation 2.61
ABUS Arbutus Biopharma Corporation 4.25
ABVC ABVC BioPharma, Inc. 2.84
ABVX Abivax SA American Depositary Shares 82.3
ACAD ACADIA Pharmaceuticals Inc. 24.42
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7948
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.82
ACIU AC Immune SA 2.45
ETFs With Exposure to SONN
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 145.4
VXF Vanguard Extended Market Index Fund 0.00011 212.09
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00011 161.01
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00011 161.03
VEMPX Vanguard Extended Market Index InstlPlus 0.00011 397.36
Unlock